Reports of heart inflammation among a small fraction of Pfizer and Moderna COVID-19 vaccine recipients, predominantly males under 30, are under review as an advisory panel to the Centers for Disease Control and Prevention is set to meet Friday.

Reports of heart inflammation among a small fraction of Pfizer and Moderna COVID-19 vaccine recipients, predominantly males under 30, are under review as an advisory panel to the Centers for Disease Control and Prevention is set to meet Friday.